This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Dawei Huang: Innovator in Pharmaceutical Delivery Systems
Introduction
Dawei Huang is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative delivery systems for therapeutic agents.
Latest Patents
Huang holds a patent for a cationic lipid compound, which is detailed in his patent titled "Cationic lipid compound, composition containing same and use thereof." This patent describes a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt, or stereoisomer thereof. The patent further outlines a composition containing the aforementioned compound and its use in the delivery of therapeutic or prophylactic agents. He has 1 patent to his name.
Career Highlights
Dawei Huang is associated with Hangzhou Tianlong Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work focuses on enhancing the efficacy of drug delivery systems, which is crucial for improving patient outcomes.
Collaborations
Huang collaborates with notable colleagues, including Gengshen Song and Huanyu Wang, to advance research and development in the pharmaceutical sector.
Conclusion
Dawei Huang's contributions to pharmaceutical innovations, particularly in drug delivery systems, highlight his role as a key inventor in the industry. His work continues to influence the development of effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile